Charles River is shuttering its pathology facility in Durham, North Carolina, after determining the site “is not a strategic ...
Charles River Laboratories (NYSE:CRL) lost ~12% in the premarket on Tuesday after the contract research organization said its 2025 revenue on an organic basis is expected to decline at a similar ...
The outlook for Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International ...
Upslope Capital Management highlighted stocks like Charles River Laboratories International, Inc. (NYSE:CRL) in the fourth quarter 2024 investor letter. Charles River Laboratories International ...
She was previously an equity research analyst for Winslow Management Co, a principal at Charles River Ventures, and an investment manager at the Massachusetts Renewable Energy Trust.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results